Merck's cholesterol pill gets U.S. FDA approval
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, Lipfendra, the first of its kind to receive the health regulator's nod.
Overview
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, Lipfendra, the first of its kind to receive the health regulator's nod.
Source
Originally published at www.cnbc.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.